A recent £5 million funding round has been secured by Edinburgh-based Calcivis to support the rollout of its dental technology for the early detection of tooth decay. The investment was led by the Scottish National Investment Bank, providing £4 million, along with an additional £1 million from IFS Maven Equity Finance managed by Maven Capital Partners.
Founded in 2012 by CEO Adam Christie and CTO Bruce Vernon, Calcivis’ imaging system uses a biologic diagnostic to enable preventative treatment before tooth decay becomes irreversible. The company plans to introduce its product in the US first, with subsequent launches planned in the UK and other European markets.
The importance of early diagnosis and treatment of tooth decay was highlighted by Adam Christie, who emphasized the potential for the technology to revolutionize preventive oral healthcare. The World Health Organization reports that cavities impact over two billion people globally, underscoring the significance of innovative solutions like Calcivis.
Paul Callaghan, investment director at the Scottish National Investment Bank, praised Calcivis for its cutting-edge technology that enhances health and wellbeing. He expressed pride in supporting the company’s expansion into international markets, creating job opportunities in Scotland. The bank sees Calcivis’ technology as aligned with its innovation mission and anticipates significant health benefits for people in Scotland from the product’s launch in the UK.
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/5KLDONQKPJA2PLOCDKPLPWAY3M.jpg)